Fuso Pharmaceutical Industries,Ltd. (4538.T) stock price, financials & research

Regular session · JST · Market data may be delayed.

Company profile

Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in the development and commercialization of pharmaceutical goods. Their product range encompasses prescription medications, particularly injectables and solutions for artificial kidney dialysis, as well as various medical instruments and apparatus. Additionally, the company participates in real estate leasing. Established in 1937, Fuso Pharmaceutical's corporate headquarters are situated in Osaka, Japan.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Headquarters: JP
CEO: Mikio Toda
Listed since: Jan 1, 2001
Employees: 1,370

Market position

Day range

Current ¥2,315

¥2,301¥2,320

52-week range

Current ¥2,315

¥1,990¥2,530

Open: ¥2,312
Previous close: ¥2,303
Volume: 12.9K; 0.6× average
Average volume: 21.51K; Average daily volume
Market cap: 19.76B JPY
Beta: 0.15; Market reference 1
50-day average: ¥2,158.46; +7.25% above average
200-day average: ¥2,240.98; +3.30% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): 9.02×
P/B (TTM): 0.55×
P/S (TTM): 0.31×
Dividend yield: 3.89%

Profitability & efficiency

Gross margin: 25.64%
Operating margin: 4.80%
Net margin: 3.49%

Financial health

Debt / equity: 0.74×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

62.31B JPY+2.88%

Operating income

2.64B JPY-36.11%

Net income

2.01B JPY+5.3B JPY

Metric (JPY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	62.31B JPY	60.56B JPY	55.41B JPY	51.02B JPY	49.63B JPY
Cost of goods sold	46.31B JPY	44.37B JPY	41.89B JPY	37.65B JPY	36.72B JPY
Gross profit	16B JPY	16.19B JPY	13.52B JPY	13.36B JPY	12.91B JPY
Research and development	—	1.72B JPY	1.47B JPY	1.35B JPY	1.44B JPY
Selling, general, and administrative	13.36B JPY	10.34B JPY	10.08B JPY	9.8B JPY	9.54B JPY
Operating expenses	13.36B JPY	12.06B JPY	11.55B JPY	11.15B JPY	10.99B JPY
Interest income	142M JPY	107M JPY	96M JPY	89M JPY	82M JPY
Interest expense	328M JPY	161M JPY	171M JPY	165M JPY	176M JPY
Depreciation and amortization	2.62B JPY	1.83B JPY	1.73B JPY	2.26B JPY	2.38B JPY
Operating income	2.64B JPY	4.13B JPY	1.97B JPY	2.21B JPY	1.92B JPY
Net income	2.01B JPY	−3.29B JPY	1.38B JPY	1.61B JPY	1.48B JPY